Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-10-2
pubmed:abstractText
Administration of gemcitabine together with cisplatin at cytotoxic doses in a chemoradiotherapy regimen is hampered by a high degree of local toxicity. Using the pharmacologic properties of the drug we designed a modified schedule aimed at reducing toxicity while preserving activity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0360-3016
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
731-7
pubmed:meshHeading
pubmed-meshheading:17011449-Adult, pubmed-meshheading:17011449-Aged, pubmed-meshheading:17011449-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17011449-Carcinoma, Squamous Cell, pubmed-meshheading:17011449-Cisplatin, pubmed-meshheading:17011449-Combined Modality Therapy, pubmed-meshheading:17011449-Deoxycytidine, pubmed-meshheading:17011449-Dose Fractionation, pubmed-meshheading:17011449-Drug Administration Schedule, pubmed-meshheading:17011449-Female, pubmed-meshheading:17011449-Head and Neck Neoplasms, pubmed-meshheading:17011449-Humans, pubmed-meshheading:17011449-Laryngeal Neoplasms, pubmed-meshheading:17011449-Male, pubmed-meshheading:17011449-Middle Aged, pubmed-meshheading:17011449-Mouth Neoplasms, pubmed-meshheading:17011449-Neoplasm Recurrence, Local, pubmed-meshheading:17011449-Neutropenia, pubmed-meshheading:17011449-Pharyngeal Neoplasms, pubmed-meshheading:17011449-Stomatitis
pubmed:year
2006
pubmed:articleTitle
Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
pubmed:affiliation
Medical Oncology, S. Croce General Hospital, Cuneo, Italy. gianmauro.numico@fastwebnet.it
pubmed:publicationType
Journal Article